Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)

NCT01552122 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Osteoporosis
Postmenopausal Osteoporosis

Interventions

DRUG: Odanacatib
DRUG: Alendronate
OTHER: Placebo (odanacatib)
DIETARY_SUPPLEMENT: Cholecalciferol (Vitamin D3)
DIETARY_SUPPLEMENT: Calcium carbonate
OTHER: Placebo (alendronate)

Sponsor

Merck Sharp & Dohme LLC